glp 1 uses GLP-1 receptor agonists GLP-1 Receptor Agonists and Research

Introduction of Generics and Oral Formulations: Market accessibility has improved through the approval of the first generic liraglutide (Victoza) earlier this year and generic exenatide last month

Association between dietary patterns and depressive symptoms over time: a 10-year follow-up study of the GAZEL cohort

177Lu-PSMA-617 gained FDA approval in 2023 for patients with PSMA-positive mCRPC after progression on ARi and taxane-based chemotherapy, following the phase III VISION trial demonstrating that the combination of 177Lu-PSMA-617 with best standard-of-care (BSoC) therapy improved median overall survival and radiographic progression-free survival compared to BSoC alone (NCT03511664) 83

134 , e178540 (2024)

The dropper bottle format also contributes to the overall product experience